BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 34601488)

  • 1. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
    Wang F; Zhang C; Cheng H; Liu C; Lu Z; Zheng S; Wang S; Sun N; He J
    Cell Death Dis; 2021 Oct; 12(10):901. PubMed ID: 34601488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
    Huang S; Zhang J; He P; Cui X; Hou Y; Su W; Li F
    BMC Cancer; 2024 May; 24(1):557. PubMed ID: 38702629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
    Liu J; Chen H; Qiao G; Zhang JT; Zhang S; Zhu C; Chen Y; Tang J; Li W; Wang S; Tian H; Chen Z; Ma D; Tian J; Wu YL
    Cancer Immunol Immunother; 2023 Apr; 72(4):881-893. PubMed ID: 36121452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
    Xia Q; Du Z; Chen M; Zhou X; Bai W; Zheng X; Lin L; Zhao Y; Ding J; Wu Z; Zou H; Wang S; Xu L; Li E; Wu B
    Mol Oncol; 2023 Nov; 17(11):2451-2471. PubMed ID: 37753805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma.
    Arora M; Kumari S; Kadian L; Anupa G; Singh J; Kumar A; Verma D; Pramanik R; Kumar S; Yadav R; Chopra A; Chauhan SS
    Biosci Rep; 2023 Sep; 43(9):. PubMed ID: 37531267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes.
    Liu M; An H; Zhang Y; Sun W; Cheng S; Wang R; Wang X; Feng L
    EBioMedicine; 2020 Jul; 57():102831. PubMed ID: 32580137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.
    Gong Q; Wang Y; Zhu K; Bai X; Feng T; Sun G; Wang M; Pan X; Qin C
    Biochem Biophys Res Commun; 2023 Oct; 676():58-65. PubMed ID: 37487438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.
    Yuan H; Zhao Z; Xu J; Zhang R; Ma L; Han J; Zhao W; Guo M; Song Y
    J Exp Clin Cancer Res; 2023 Sep; 42(1):249. PubMed ID: 37752569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma.
    Hong P; Xu T; Xu J; Chen W; Hu H; Chen J; Li L; Zheng C; Li B; Liu J; Dai W; Li E; Zhang F; Xu W
    Cancer Lett; 2024 May; 594():216994. PubMed ID: 38801885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
    Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
    Cancer Biol Ther; 2024 Dec; 25(1):2302162. PubMed ID: 38241178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermia inhibits the progression of gastric cancer by downregulating PLEK2/PD-L1 and possibly participates in immunomodulation.
    Li K; Feng J; Deng J; Shi H; Peng R; Zhang X
    Gene; 2024 Mar; 898():148111. PubMed ID: 38147897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer.
    Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14641-14655. PubMed ID: 37584712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy.
    Fuchino T; Kurogi S; Tsukamoto Y; Shibata T; Fumoto S; Fujishima H; Kinoshita K; Hirashita Y; Fukuda M; Nakada C; Itai Y; Suzuki K; Uchida T; Shiroshita H; Matsumoto T; Yamaoka Y; Tsutsumi K; Fukuda K; Ogawa R; Mizukami K; Kodama M; Inomata M; Murakami K; Moriyama M; Hijiya N
    Hum Cell; 2024 Mar; 37(2):491-501. PubMed ID: 38184488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Zhang Z; Zhang C; Yang Z; Zhang G; Wu P; Luo Y; Zeng Q; Wang L; Xue Q; Zhang Y; Sun N; He J
    J Hematol Oncol; 2021 Nov; 14(1):190. PubMed ID: 34758859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma.
    Zhao M; Li M; Zheng Y; Hu Z; Liang J; Bi G; Bian Y; Sui Q; Zhan C; Lin M; Wang Q
    J Cancer; 2022; 13(5):1611-1622. PubMed ID: 35371305
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
    Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
    Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumor heterogeneity associated with KRAS/TP53 co-mutation status in lung adenocarcinoma based on single-cell RNA sequencing.
    Ye YH; Zhang YT; Luo YL; Xu AP; Ji L
    Am J Cancer Res; 2024; 14(2):655-678. PubMed ID: 38455404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of a Hypoxia and Glycolysis Prognostic Signatures in Lung Adenocarcinoma.
    Zhao W; Ding C; Zhao M; Li Y; Huang H; Li X; Cheng Q; Shi Z; Gao W; Liu H; Chen J
    J Cancer; 2024; 15(6):1568-1582. PubMed ID: 38370379
    [No Abstract]   [Full Text] [Related]  

  • 19. CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway.
    Xia X; Zhao S; Chen W; Xu C; Zhao D
    Ir J Med Sci; 2023 Dec; 192(6):2653-2660. PubMed ID: 37017854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleckstrin-2-promoted PPM1B degradation plays an important role in transforming growth factor-β-induced breast cancer cell invasion and metastasis.
    Du L; Li J; Tian Y; Feng R
    Cancer Sci; 2023 Jun; 114(6):2429-2444. PubMed ID: 36928924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.